- Препоръки за медицински контрол на гърдата и схема на периодично лечение (20 дни, последвани от 10- дневен период на почивка), за да се намали рискът от хиперпролактинемия, с
-Recommendations of medical breast monitoring and intermittent schedule (20 days followed by a 10- day period of non-treatment) to reduce the risk of hyperprolactinemia, aimed to improve the breast safety (however, it is unknown whether this measure has any effect on the observed adverse event pattern related to hyperprolactinemia like breast enlargement, galactorrhoea and risk for patients with prolactin-dependent tumours such as pituitary gland prolactinoma and breast cancer).